The global Protein Labeling Market size is expected to reach USD 4.11 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2022 to 2030. The study of Post-translational Modification (PTM) of proteins has gained immense popularity in cell biology and disease treatment and prevention. The introduction of effective quantification methods of protein expression with the use of tagging strategies, such as iodoTMTzero Label Reagent that detects nitrosylation, has driven an efficient determination of PTMs. Therefore, a rise in PTM-related studies is driving the market. The emergence of novel techniques and the launch of improved products are expected to positively influence market growth.
One such development includes the application of new
spin labels that expand the capability of site-directed spin labeling of
proteins. These labels in combination with electron paramagnetic resonance
spectroscopy (SDSL-EPR) enable the investigation of protein structure,
dynamics, and structural heterogeneity. The market is growing as private
players and government agencies increased investments in proteomics and
genomics R&D. Proteomics is the study of the entire protein content of a
cell, tissue, or organism. Proteomic profiling approaches require protein labeling
methods before separation and analysis. For example, the United States National
Institutes of Health (NIH) allocated USD 37 billion to scientific research.
Moreover, there is an increase in funding for life
sciences research that supports molecular studies to better understand the
fundamental processes by which diseases emerge, as well as the identification
of biomarkers that identify the presence of disease or the gene/protein
responsible for the condition. The Novo Nordisk Foundation awarded the
University of Copenhagen a grant of up to USD 1.5 million to create a mass
spectrometry facility, which is a new and exciting step in protein research. As
a result, the market is being driven by increased spending on proteomics and
genomics research and development. Protein labeling applications are widely
employed for a variety of functions. Cell-based assays can offer information
about intracellular molecular targets and have the advantage of being performed
in a biological context.
Fluorescent antibodies are important in clinical
therapy as well as for investigating immunology, cell biology, and
neuroscience. A mass spectrometer is a device that detects the m/z ratio of
ions to identify and quantify compounds in simple and complicated mixtures. It
has proven indispensable in a variety of domains and applications, including
proteomics. Immunological approaches include ways of studying the immune system
as well as the application of immunological reagents as instruments. Protein
microarrays are a new type of proteomic technology that is rapidly gaining
popularity in molecular biology and biochemistry.
Related Press Release@ Protein Labeling Market Report
Protein Labeling Market Report
Highlights
- Proteins dominated the reagents segment in 2021 as fluorescent
proteins are beneficial and allow in situ fusion expression through gene
transfer into cells
- This eliminates the need for purification, in vitro labeling,
high-level heterologous production, and microinjection of recombinant
proteins
- The fluorescence microscopy segment is estimated to register the
fastest CAGR from 2022 to 2030 due to the development of monomeric
fluorescent proteins that are capable to fluoresce orange to far-red bands
of the visible light spectrum
- The in-vitro labeling segment accounted for the largest revenue
share in 2021 and is anticipated to witness the fastest CAGR during the
forecast period
- The less complexity associated with in-vitro techniques and the
availability of a large number of commercial kits for these techniques
result in a larger share of the segment in 2021
- North America accounted for the maximum revenue share in 2021 due
to the presence of key manufacturers, increase in proteomics research, the
advent of bioengineering technologies, and high adoption of these products
in disease diagnosis-associated studies
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment